-
Nov 27, 2024 | 
radcliffecardiology.com | Harriette Van Spall |Marianna Fontana |Andrew Coats |Milind Y. Desai
Video Published: Views: 34 Likes: 0 Average (ratings) AHA Conference 2024 - Safety and efficacy outcomes of nexiguran ziclumeran (NTLA-2001) in patients with transthyretin amyloidosis with cardiomyopathy (ATTR-CM). Dr Marianna Fontana (University College London, London, UK) joins us onsite at AHA Conference to discuss the findings from the nexiguran ziclumeran for ATTR-CM trial (NCT04601051).
-
Nov 27, 2024 | 
radcliffecardiology.com | Sanjiv Shah |Ashley Park |Andrew Coats |Nazli Okumus
Video Published: Views: 22 Likes: 0 Average (ratings) AHA Conference 2024 - Primary safety and efficacy results from ENDEAVOR investigating the effect of myeloperoxidase inhibition with mitiperstat (AstraZeneca) on symptoms and exercise capacity in patients with heart failure with preserved or mildly reduced ejection fraction (HFpEF/HFmrEF).
-
Nov 26, 2024 | 
radcliffecardiology.com | Harriette Van Spall |Andrew Coats |Julia Grapsa
AHA Conference 2024 - Discover the findings from a new study on the impact of diastolic dysfunction on the efficacy of empagliflozin in heart failure in the EMPEROR-Preserved trial. Prof Andrew Coats (Heart Research Institute, New South Wales, AU) joins us onsite at AHA Conference to discuss findings from a new analysis of diastolic dysfunction in the EMPEROR-Preserved trial (NCT03057951).
-
Nov 7, 2024 | 
radcliffecvrm.com | Andrew Coats |Brad H Rovin |Jürgen Floege |Muthiah Vaduganathan
Long-term cardio-renal outcomes investigating empagliflozin (Boehringer Ingelheim) on kidney disease progression (KDP) or cardiovascular death in patients with pre-existing chronic kidney disease. In this short interview, Prof William Herrington (Nuffield Department of Population Health, University of Oxford, Oxford, UK) discusses the findings from EMPA-KIDNEY (NCT03594110).
-
Aug 5, 2024 | 
erj.ersjournals.com | Marc Humbert |Roberto Badagliacca |Andrew Coats |George Giannakoulas
According to the revised haemodynamic definition, PAH may be diagnosed in patients with mPAP >20 mmHg and PVR >2 WU. Yet, the efficacy of drugs approved for PAH has only been demonstrated in patients with mPAP ≥25 mmHg and PVR >3 WU (see , ). No data are available for the efficacy of drugs approved for PAH in patients whose mPAP is <25 mmHg and whose PVR is <3 WU. Hence, for such patients, the efficacy of drugs approved for PAH has not been established.
-
Dec 29, 2023 | 
onlinelibrary.wiley.com | Andrew Coats |Javed Butler |Baylor Scott |Hiroyuki Tsutsui
Introduction Frailty is becoming more common as the populations of the world age and as previously fatal conditions are being managed better, thereby allowing patients to survive longer whilst accumulating an increased burden of co-morbidities.1 There is no precise definition of frailty as it is a combination of multiple physiological and pathological deficiencies that lead to a reduction in the reserve capacity of the body to cope with physiological or physical stressors, as recently...
-
Dec 26, 2023 | 
onlinelibrary.wiley.com | Stephan von Haehling |Andrew Coats |Stefan Anker
The Journal of Cachexia, Sarcopenia and Muscle (JCSM) is a peer-reviewed international journal dedicated to publishing materials that are related to cachexia and sarcopenia as well as to body composition and its physiological and pathophysiological changes during the life span and in different illnesses from all fields of the life sciences.
-
Nov 30, 2023 | 
evangelical-times.org | Andrew Coats
Authors: Sam Waldron Publisher: Evangelical Press 393 pages Purchase from: EP Books (£15.99) Some readers may have been given a Christmas hamper. When the hamper is opened you expect the usual fare of mince pies and Christmas puddings, but delving into the wood-shavings brings more and more pleasant discoveries of cake, biscuits, nuts, and chocolates. That is what you will find with How Then Should We Worship? by Sam Waldron.
-
Oct 28, 2023 | 
onlinelibrary.wiley.com | Ivan Aprahamian |Andrew Coats |John Morley |Tatiana Klompenhouwer
Introduction Anorexia of aging is a common geriatric syndrome that includes loss of appetite and/or reduced food intake, with associated undernutrition, unintended weight loss, reduced immune status, frailty, sarcopenia, functional decline, loss of independence, poor quality of life and other adverse health outcomes.1-5 In older populations, the incidence of anorexia of aging ranges from 25% (community dwellers) to 85% (nursing homes) depending on individual circumstances, and given the...
-
Oct 13, 2023 | 
radcliffecardiology.com | Andrew Coats
Skip to main content Overview Broadcast live from Nice, France, "Guideline Controversies" will bring together over 25 global experts to discuss the most pertinent challenges facing guidelines, with a focus on heart failure.
This engaging meeting is designed to ignite insightful discussions, foster innovative thinking, and uncover new perspectives.
